Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-005350-29Phase 4Completed
Phase 4, randomised trial of albumin (human) in abnormal coagulation profile and coagulation and blood loss (2 arms), sponsored by Rigshospitalet. Primary endpoint: Coagulation competence. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-005350-29.